These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38905890)

  • 1. A novel risk scoring system predicts overall survival of hepatocellular carcinoma using cox proportional hazards machine learning method.
    Xin H; Li Y; Wang Q; Liu R; Zhang C; Zhang H; Su X; Bai B; Li N; Zhang M
    Comput Biol Med; 2024 Aug; 178():108663. PubMed ID: 38905890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and Validation of the Novel Necroptosis-related Genes for Predicting Stemness and Immunity of Hepatocellular Carcinoma
    Li YT; Zeng XZ
    Comb Chem High Throughput Screen; 2025; 28(1):146-165. PubMed ID: 39641162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.
    de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH
    Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Analysis of Radiofrequency Ablation in Patients with Small Solitary Hepatocellular Carcinoma: Survival Outcomes and Development of a Machine Learning Prognostic Model.
    He QF; Xiong Y; Yu YH; Meng XC; Ma TX; Chen ZH
    Curr Med Sci; 2024 Oct; 44(5):1006-1017. PubMed ID: 39347922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learning.
    Gross M; Haider SP; Ze'evi T; Huber S; Arora S; Kucukkaya AS; Iseke S; Gebauer B; Fleckenstein F; Dewey M; Jaffe A; Strazzabosco M; Chapiro J; Onofrey JA
    Eur Radiol; 2024 Oct; 34(10):6940-6952. PubMed ID: 38536464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Risk Factors, and Development and Validation of Prognostic Prediction Models for Distant Metastasis in Patients With Rectal Cancer: A Study Based on the SEER Database and a Chinese Population.
    Zhang H; Wang H; Yao Y; Liu L; Feng F; Li H; Sun C
    Cancer Control; 2024; 31():10732748241303650. PubMed ID: 39579008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of biomarkers and dosimetry parameters in overall and progression free survival prediction for patients treated with personalized
    Mansouri Z; Salimi Y; Hajianfar G; Wolf NB; Knappe L; Xhepa G; Gleyzolle A; Ricoeur A; Garibotto V; Mainta I; Zaidi H
    Eur J Nucl Med Mol Imaging; 2024 Nov; 51(13):4111-4126. PubMed ID: 38981950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the CD8
    Fan J; Zhang Q; Huang T; Li H; Fang G
    Transl Cancer Res; 2024 Nov; 13(11):5856-5872. PubMed ID: 39697729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis.
    Allotey J; Archer L; Coomar D; Snell KI; Smuk M; Oakey L; Haqnawaz S; Betrán AP; Chappell LC; Ganzevoort W; Gordijn S; Khalil A; Mol BW; Morris RK; Myers J; Papageorghiou AT; Thilaganathan B; Da Silva Costa F; Facchinetti F; Coomarasamy A; Ohkuchi A; Eskild A; Arenas Ramírez J; Galindo A; Herraiz I; Prefumo F; Saito S; Sletner L; Cecatti JG; Gabbay-Benziv R; Goffinet F; Baschat AA; Souza RT; Mone F; Farrar D; Heinonen S; Salvesen KÅ; Smits LJ; Bhattacharya S; Nagata C; Takeda S; van Gelder MM; Anggraini D; Yeo S; West J; Zamora J; Mistry H; Riley RD; Thangaratinam S
    Health Technol Assess; 2024 Aug; 28(47):1-119. PubMed ID: 39252507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in the context of interventions for improving health literacy in migrants: a qualitative evidence synthesis.
    Aldin A; Baumeister PhD A; Chakraverty D; Monsef I; Noyes J; Kalbe E; Woopen C; Skoetz N
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD013302. PubMed ID: 39665382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.
    O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H
    Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning-based ultrasomics for predicting response to tyrosine kinase inhibitor in combination with anti-PD-1 antibody immunotherapy in hepatocellular carcinoma: a two-center study.
    Hu Y; Zhang L; Qi Q; Ren S; Wang S; Yang L; Zhang J; Liu Y; Li X; Cai X; Duan S; Zhang L
    Front Oncol; 2024; 14():1464735. PubMed ID: 39610931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imaging.
    Dadu A; Ta M; Tustison NJ; Daneshmand A; Marek K; Singleton AB; Campbell RH; Nalls MA; Iwaki H; Avants B; Faghri F
    medRxiv; 2024 Oct; ():. PubMed ID: 39574848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signature of immune-related metabolic genes predicts the prognosis of hepatocellular carcinoma.
    Zhuo W; Xia H; Lan B; Chen Y; Wang X; Liu J
    Front Immunol; 2024; 15():1481331. PubMed ID: 39654885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.